{"bill":{"bill_id":1649510,"change_hash":"6a38187bddb7114eddd1319ecc273f19","session_id":2021,"session":{"session_id":2021,"state_id":14,"year_start":2023,"year_end":2023,"prefile":0,"sine_die":0,"prior":0,"special":0,"session_tag":"Regular Session","session_title":"2023 Regular Session","session_name":"2023 Regular Session"},"url":"https:\/\/legiscan.com\/IN\/bill\/HB1095\/2023","state_link":"https:\/\/iga.in.gov\/legislative\/2023\/bills\/house\/1095\/","completed":0,"status":1,"status_date":"2023-01-10","progress":[{"date":"2023-01-10","event":1},{"date":"2023-01-10","event":9}],"state":"IN","state_id":14,"bill_number":"HB1095","bill_type":"B","bill_type_id":"1","body":"H","body_id":37,"current_body":"H","current_body_id":37,"title":"Mental health and addiction matters.","description":"Mental health and addiction matters. Specifies that an individual's incarceration, hospitalization, or other temporary cessation in substance or chemical use may not be used as a factor in determining the individual's eligibility for coverage in: (1) a state employee health care plan; (2) Medicaid; (3) the healthy Indiana plan; (4) a policy of accident and sickness insurance; or (5) a health maintenance health care contract. Requires an opioid treatment program to: (1) provide a patient of the facility appropriate referrals for continuing care before releasing the patient from care by the facility; and (2) counsel female patients concerning the effects of the program treatment if the female is or becomes pregnant and provide to the patient birth control if requested by the patient. Requires the division of mental health and addiction (division) to annually perform an audit of 20% of an opioid treatment program facility's patient plans to ensure compliance with federal and state laws and regulations. Requires the division to establish a mental health and addiction program to reduce the stigma of mental illness and addiction. Requires hospitals to establish emergency room treatment protocols concerning treatment of a patient who is overdosing, has been provided an overdose intervention drug, or is otherwise identified as having a substance use disorder.","pending_committee_id":1300,"committee":{"committee_id":1300,"chamber":"H","chamber_id":37,"name":"Public Health"},"referrals":[{"date":"2023-01-10","committee_id":1300,"chamber":"H","chamber_id":37,"name":"Public Health"}],"history":[{"date":"2023-01-10","action":"Authored by Representative Shackleford","chamber":"H","chamber_id":37,"importance":0},{"date":"2023-01-10","action":"First reading: referred to Committee on Public Health","chamber":"H","chamber_id":37,"importance":1}],"sponsors":[{"people_id":14446,"person_hash":"loqglkk5","party_id":"1","state_id":14,"party":"D","role_id":1,"role":"Rep","name":"Robin Shackleford","first_name":"Robin","middle_name":"","last_name":"Shackleford","suffix":"","nickname":"","district":"HD-098","ftm_eid":6500220,"votesmart_id":120367,"opensecrets_id":"","knowwho_pid":289900,"ballotpedia":"Robin_Shackleford","bioguide_id":"","sponsor_type_id":1,"sponsor_order":1,"committee_sponsor":0,"committee_id":0,"state_federal":0}],"sasts":[],"subjects":[],"texts":[{"doc_id":2629555,"date":"2023-01-09","type":"Introduced","type_id":1,"mime":"application\/pdf","mime_id":2,"url":"https:\/\/legiscan.com\/IN\/text\/HB1095\/id\/2629555","state_link":"https:\/\/iga.in.gov\/legislative\/2023\/bills\/house\/1095\/#1.INTR","text_size":227481,"text_hash":"22c9d07efcad13486c027f86b18d171b"}],"votes":[],"amendments":[],"supplements":[],"calendar":[]}}